Meganuclease targeting HSV-1 limits viral endothelitis in vivo
Acta Ophthalmologica, 08/17/2012
Chapellier B et al. – Meganuclease gene therapy targeting HSV–1 DNA restricts degradation of the endothelium initiated by HSV–1 injection.



